These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 10229197)

  • 41. Histone acetylation may suppress human glioma cell proliferation when p21 WAF/Cip1 and gelsolin are induced.
    Kamitani H; Taniura S; Watanabe K; Sakamoto M; Watanabe T; Eling T
    Neuro Oncol; 2002 Apr; 4(2):95-101. PubMed ID: 11916500
    [TBL] [Abstract][Full Text] [Related]  

  • 42. p53-independent upregulation of p21WAF1 in NIH 3T3 cells malignantly transformed by mot-2.
    Takano S; Wadhwa R; Mitsui Y; Kaul SC
    Cell Res; 2001 Mar; 11(1):55-60. PubMed ID: 11305325
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Trichostatin and leptomycin. Inhibition of histone deacetylation and signal-dependent nuclear export.
    Yoshida M; Horinouchi S
    Ann N Y Acad Sci; 1999; 886():23-36. PubMed ID: 10667200
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of mitogenesis in Balb/c-3T3 cells by Trichostatin A. Multiple alterations in the induction and activation of cyclin-cyclin-dependent kinase complexes.
    Wharton W; Savell J; Cress WD; Seto E; Pledger WJ
    J Biol Chem; 2000 Oct; 275(43):33981-7. PubMed ID: 10945992
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Panaxadiol selectively inhibits cyclin A-associated Cdk2 activity by elevating p21WAF1/CIP1 protein levels in mammalian cells.
    Jin YH; Choi J; Shin S; Lee KY; Park JH; Lee SK
    Carcinogenesis; 2003 Nov; 24(11):1767-72. PubMed ID: 12819186
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HDAC Inhibitor Oxamflatin Induces Morphological Changes and has Strong Cytostatic Effects in Ovarian Cancer Cell Lines.
    Wang YL; Liui HL; Fu RG; Wang ZW; Ren HT; Dai ZJ; Jing YY; Li Y
    Curr Mol Med; 2016; 16(3):232-42. PubMed ID: 26917266
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Superior activity of a new histone deacetylase inhibitor (ZYJ-34c) in inhibiting growth of human leukemia cells by inducing p21WAF1 expression and cell cycle arrest.
    Yang H; Xu W; Li Y; Lan P; Zhang J; Zhang Y; Zhang C
    Anticancer Drugs; 2014 Aug; 25(7):767-77. PubMed ID: 24686006
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of p21Waf1/Cip1 and cyclin D1 is increased in butyrate-resistant HeLa cells.
    Derjuga A; Richard C; Crosato M; Wright PS; Chalifour L; Valdez J; Barraso A; Crissman HA; Nishioka W; Bradbury EM; Th'ng JP
    J Biol Chem; 2001 Oct; 276(41):37815-20. PubMed ID: 11477082
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Depsipeptide (FR901228) inhibits proliferation and induces apoptosis in primary and metastatic human uveal melanoma cell lines.
    Klisovic DD; Katz SE; Effron D; Klisovic MI; Wickham J; Parthun MR; Guimond M; Marcucci G
    Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2390-8. PubMed ID: 12766035
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Functional interplay between modulation of histone deacetylase activity and its regulatory role in G2-M transition.
    Noh EJ; Lee JS
    Biochem Biophys Res Commun; 2003 Oct; 310(2):267-73. PubMed ID: 14521905
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel hydroxamate and anilide derivatives as potent histone deacetylase inhibitors: synthesis and antiproliferative evaluation.
    Bouchain G; Delorme D
    Curr Med Chem; 2003 Nov; 10(22):2359-72. PubMed ID: 14529479
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression.
    Siavoshian S; Segain JP; Kornprobst M; Bonnet C; Cherbut C; Galmiche JP; Blottière HM
    Gut; 2000 Apr; 46(4):507-14. PubMed ID: 10716680
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antitumor effects of a novel histone deacetylase inhibitor NK-HDAC-1 on breast cancer.
    Li ZH; Zhang XB; Han XQ; Feng CR; Wang FS; Wang PG; Shen J; Shi YK
    Oncol Rep; 2013 Jul; 30(1):499-505. PubMed ID: 23624828
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The histone deacetylase inhibitor Trichostatin A modulates CD4+ T cell responses.
    Moreira JM; Scheipers P; Sørensen P
    BMC Cancer; 2003 Nov; 3():30. PubMed ID: 14606959
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oestrogen receptor alpha increases p21(WAF1/CIP1) gene expression and the antiproliferative activity of histone deacetylase inhibitors in human breast cancer cells.
    Margueron R; Licznar A; Lazennec G; Vignon F; Cavaillès V
    J Endocrinol; 2003 Oct; 179(1):41-53. PubMed ID: 14529564
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells.
    Takai N; Desmond JC; Kumagai T; Gui D; Said JW; Whittaker S; Miyakawa I; Koeffler HP
    Clin Cancer Res; 2004 Feb; 10(3):1141-9. PubMed ID: 14871994
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Histone deacetylase inhibitor, trichostatin A induces ubiquitin-dependent cyclin D1 degradation in MCF-7 breast cancer cells.
    Alao JP; Stavropoulou AV; Lam EW; Coombes RC; Vigushin DM
    Mol Cancer; 2006 Feb; 5():8. PubMed ID: 16504004
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cyclin A downregulation and p21(cip1) upregulation correlate with GATA-6-induced growth arrest in glomerular mesangial cells.
    Nagata D; Suzuki E; Nishimatsu H; Yoshizumi M; Mano T; Walsh K; Sata M; Kakoki M; Goto A; Omata M; Hirata Y
    Circ Res; 2000 Oct; 87(8):699-704. PubMed ID: 11029406
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Histone deacetylase as a new target for cancer chemotherapy.
    Yoshida M; Furumai R; Nishiyama M; Komatsu Y; Nishino N; Horinouchi S
    Cancer Chemother Pharmacol; 2001 Aug; 48 Suppl 1():S20-6. PubMed ID: 11587361
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Histone deacetylase inhibitor activates the p21/WAF1/Cip1 gene promoter through the Sp1 sites.
    Sowa Y; Orita T; Hiranabe-Minamikawa S; Nakano K; Mizuno T; Nomura H; Sakai T
    Ann N Y Acad Sci; 1999; 886():195-9. PubMed ID: 10667218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.